Vaccines Market Research Reports & Industry Analysis
Because of the large number of deadly diseases that have been eliminated through the proliferation of effective vaccines, vaccination is generally viewed as one of the greatest public health achievements of the 20th century. Key issues in the global vaccine market today include unequal access to vaccines, supply chain disruptions, the use of vaccines to prevent pandemics and address bioterrorism, technological innovations, and vaccine hesitancy. Learn more about this critical field with the comprehensive selection of vaccine market research reports available on MarketResearch.com.
New Vaccines Market Data and Insights
- Find data on vaccine market size segmented by region, technology, distribution channel, type, route of administration, and disease.
- Gain a deep understanding of vaccine industry dynamics, market structure, growth outlook, and competitive landscape.
- Learn about influential government initiatives and new vaccination technologies that have highly promising results.
Your Source for Expert Data and Analysis
MarketResearch.com is a trusted research partner, backed by over two decades of experience. Our clients include top investment banks, management consulting firms, and leading multinational companies within the Fortune 500. Our team of research specialists is dedicated to guiding you at every step, ensuring you have the resources and insights you need to answer your toughest research questions. Browse our full list of vaccines industry reports today.
Vaccines Industry Research & Market Reports
-
Global Microcarrier Market Report By Application (Vaccine Manufacturing, Cell Therapy, Others) Product Type (Consumables ((Microcarrier Beads, Media & Reagents)), Equipment), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, Academic & Research Institutes), Countries and Company Analysis 2024-2032
... Research Institutes), Countries and Company Analysis 2024-2032 Global Microcarrier Market Analysis Global microcarrier market will reach US$ 1.91 billion in 2022 to US$ 4. 07 billion by 2032, with a compound annual growth rate of ... Read More
-
Single-Use Bioreactors Market Report by Product Type (Single-use Bioreactor Systems, Media Bags, Filtration Assemblies, and Others), Type (Stirred-tank Bioreactors, Wave-induced Bioreactors, Bubble-column Bioreactors, and Others), Cell Type (Mammalian Cell, Bacteria, Yeast, and Others), Molecule Type (Vaccines, Monoclonal Antibodies, Stem Cells, Recombinant Proteins, and Others), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Academic and Research Institutes, and Others), and Region 2024-2032
... (Vaccines, Monoclonal Antibodies, Stem Cells, Recombinant Proteins, and Others), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Academic and Research Institutes, and Others), and Region 2024-2032 The global single-use bioreactors market size reached US$ ... Read More
-
Veterinary Medicine Market Report by Product (Drugs, Vaccines, Medicated Feed Additives), Animal Type (Production, Companion), Route of Administration (Oral, Parenteral, Topical), Distribution Channel (Veterinary Hospitals and Clinics, Point-of-Care Testing/In-house Testing, and Others), and Region 2024-2032
... The global veterinary medicine market size reached US$ 35.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 59.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032. ... Read More
-
Global Poultry Killed Vaccines Market Growth 2024-2030
... the Poultry Killed Vaccines is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Poultry Killed ... Read More
-
Global Poultry and Livestock Vaccines Market Growth 2024-2030
... downstream market, the Poultry and Livestock Vaccines is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Global Livestock Vaccines Market Growth 2024-2030
... Vaccines is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Livestock Vaccines market. Livestock Vaccines ... Read More
-
Global Tick-borne Encephalitis Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. The major factors that drive the growth of global tick-borne encephalitis vaccine, inactivated ... Read More
-
Cancer Immunotherapy Market Share, Size, Trends, Industry Analysis Report, By Type (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators); By Application; By End-User; By Region; Segment Forecast, 2024 - 2032
... market size is expected to reach USD 264.63 Billion by 2032, according to a new study by Polaris Market Research. The report “Cancer Immunotherapy Market Share, Size, Trends, Industry Analysis Report, By Type (Monoclonal Antibodies, ... Read More
-
Inactivated Vaccines Market (Vaccine Type: Viral Vaccine and Bacterial Vaccine; and Method of Inactivation: Solvent Detergent Method, Radiation Method, pH Concentration, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... Vaccines Market – Scope of Report TMR’s report on the global inactivated vaccines market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the ... Read More
-
Global Lyme Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... million in 2023 and is forecast to a readjusted size of USD 465.7 million by 2030 with a CAGR of 8.4% during review period. The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms ... Read More
-
Global Ebola Virus Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... million in 2023 and is forecast to a readjusted size of USD 232.5 million by 2030 with a CAGR of 6.0% during review period. Ebola vaccine refers to the biological products made from the pathogenic ... Read More
-
Asia Pacific Veterinary Vaccines Market, By Vaccine Type (Poultry Vaccine, Livestock Vaccines (Bovine Vaccines, Small Ruminant Vaccines), Companion Animal Vaccines (Feline Vaccines, Canine Vaccines), Aquaculture Vaccine); By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines); By Disease (Porcine Disease, Poultry Disease, Livestock Disease, Companion Animal Disease); By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... Recombinant Vaccines, Conjugate Vaccines); By Disease (Porcine Disease, Poultry Disease, Livestock Disease, Companion Animal Disease); By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Trend Analysis, ... Read More
-
Global Biodefense Market 2024-2028
... holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and ... Read More
-
2024 Global: Measles, Mumps And Rubella (Mmr) Vaccines Market - Innovative Markets Forecast (2030) report
... projected growth/decline and regional data for the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and ... Read More
-
2024 Global: Influenza Vaccination Market - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
2024 Global: Live Attenuated Vaccines Market - Innovative Markets Forecast (2030) report
... the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 ... Read More
-
2024 Global: Microneedle Flu Vaccine Market - Innovative Markets Forecast (2030) report
... the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 ... Read More
-
2024 Global: Meningococcal Vaccine Market - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
Single Use Bioprocessing Market Size, Share & Trends by Product (Equipment (Bioreactors, Mixers, Filtration, Chromatography), Consumables (Filters, Bags, Assemblies, Sensors)), Application, Workflow, Molecule Type (mAbs, Vaccines, CGT, Peptides) - Global
... single-use bioprocessing market is projected to reach USD 34.9 billion by 2029 from USD 17.7 billion in 2024, at a CAGR of 14.5% during the forecast period of 2024 to 2029. The growth of this ... Read More
-
Exosome Research Market Assessment, By Product and Service [Kits and Reagents, Instruments, Services], By Indication Type [Cancer, Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, Others], By Application Type [Biomarkers, Vaccine Development, Tissue Regeneration, Others], By End-user [Pharmaceutical and Biotechnological Companies, Hospitals and Clinical Testing Laboratories, Academic and Research Institutes], By Region, Opportunities and Forecast, 2017-2031F
... [Pharmaceutical and Biotechnological Companies, Hospitals and Clinical Testing Laboratories, Academic and Research Institutes], By Region, Opportunities and Forecast, 2017-2031F Global exosome research market is projected to witness a CAGR of 17.37% during the forecast period ... Read More
-
Global mRNA Vaccines and Treatment Drugs Competitive Landscape Professional Research Report 2024
... cells to produce specific proteins or antigens, triggering an immune response in the body. In the context of vaccines, mRNA vaccines, like those developed for COVID-19, deliver genetic instructions that enable the recipient＇s cells to ... Read More
-
Global Tuberculosis Vaccine Treatment Competitive Landscape Professional Research Report 2024
... produce antibodies and cellular immune responses against the tuberculosis bacilli. This vaccine is usually given after birth or in early childhood to prevent the development and spread of TB. Although tuberculin vaccine is a routine ... Read More
-
Global DNA Vaccines Competitive Landscape Professional Research Report 2024
... containing genetic information from a pathogen, typically a virus or bacterium. When administered to a host, usually through injection, the DNA is taken up by host cells, which then use the genetic information to produce ... Read More
-
Global DNA Vaccines Competitive Landscape Professional Research Report 2024
... pathogens. Unlike traditional vaccines that contain weakened or inactivated viruses or proteins, DNA vaccines consist of genes encoding antigens—proteins present on the surface of pathogens. When these DNA molecules are introduced into the body through ... Read More
-
Global mRNA Cancer Vaccines and Therapeutics Competitive Landscape Professional Research Report 2024
... mRNA molecules to instruct the patient＇s own cells to produce specific proteins or antigens that stimulate the immune system to recognize and target cancer cells. mRNA cancer vaccines can be tailored to an individual＇s unique ... Read More
Research Assistance
